Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sino Biopharmaceutical (SBMFF) vs. Competitors

45 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
SBMFFSino Biopharmaceutical$0.67$12.39B34.86-26.76%Strong BuyUnlock the SBMFF analyst price target with TipRanks PremiumSBMFFUnlock the SBMFF top-analyst price target with TipRanks Premium
HK:1801Innovent BiologicsHKD 85.80HKD 149.97B102.93-5.51%Strong BuyUnlock the HK:1801 analyst price target with TipRanks PremiumSBMFF vs HK:1801Unlock the HK:1801 top-analyst price target with TipRanks Premium
HK:15303SBioHKD 13.86HKD 35.19B3.54-58.13%Strong BuyUnlock the HK:1530 analyst price target with TipRanks PremiumSBMFF vs HK:1530Unlock the HK:1530 top-analyst price target with TipRanks Premium
HK:9926Akeso, Inc.HKD 61.90HKD 58.26B-50.54-46.73%Strong BuyUnlock the HK:9926 analyst price target with TipRanks PremiumSBMFF vs HK:9926Unlock the HK:9926 top-analyst price target with TipRanks Premium
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class HHKD 14.11HKD 27.62B-63.54-42.97%Strong BuyUnlock the HK:1877 analyst price target with TipRanks PremiumSBMFF vs HK:1877Unlock the HK:1877 top-analyst price target with TipRanks Premium
HK:2696Shanghai Henlius Biotech, Inc. Class HHKD 43.88HKD 23.93B23.43-32.75%Strong BuyUnlock the HK:2696 analyst price target with TipRanks PremiumSBMFF vs HK:2696Unlock the HK:2696 top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
SBMFFSino Biopharmaceutical0.67-0.23-25.45%
HK:1801Innovent Biologics85.80-3.85-4.29%
HK:15303SBio13.86-17.85-56.29%
HK:9926Akeso, Inc.61.90-49.90-44.63%
HK:1877Shanghai Junshi Biosciences Co., Ltd. Class H14.11-10.15-41.84%
HK:2696Shanghai Henlius Biotech, Inc. Class H43.88-20.57-31.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts